期刊文献+

射频消融联合肝动脉化疗栓塞治疗原发性肝癌的临床探讨

下载PDF
导出
摘要 目的探究射频消融联合肝动脉化疗栓塞治疗原发性肝癌的临床治疗效果。方法选取收治的原发性肝癌患者36例作为研究对象,根据36例原发性肝癌患者的住院时间分为对照组与观察组,每组18例,对照组患者入院确诊后仅应用肝动脉介入化疗栓塞治疗,观察组患者入院确诊后应用射频消融联合肝动脉化疗栓塞治疗,对比观察调查随访2年内的肿瘤坏死率与术后生存时间。结果经随访调查结果统计显示,观察组患者的肿瘤完全坏死率为94. 44%(17/18),对照组患者的完全肿瘤坏死率为55. 56%(10/18)。结论射频消融联合肝动脉化疗栓塞治疗原发性肝癌的临床治疗效果显著,可使肿瘤组织坏死率显著提高,提高患者近期生存率。
作者 杨青松
出处 《航空航天医学杂志》 2018年第10期1227-1228,共2页 Journal of Aerospace medicine
  • 相关文献

参考文献5

二级参考文献49

  • 1Peng Liu,Jia-Mei Yang,Wen-Yang Niu,Tong Kan,Feng Xie,Dian-Qi Li,Ye Wang,Yan-Ming Zhou,Department of Special Treatment and Liver Transplantation,Eastern Hepatobiliary Surgery Hospital,Second Military Medical University,Shanghai 200438,China Peng Liu,Department of Hepatobiliary Surgery,Navy General Hospital,Beijing 100037,China.Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(9):1123-1128. 被引量:14
  • 2Kaneko S, Urabe T, Kobayashi K. Combination chemo- therapy {or advanced hepatocellular carcinoma complicat- ed by major portal vein thrombosis[J]. Oncology, 2002, 62(1) :69-73.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statis- tics[J]. CA Cancer J Clin,2011,61(6) ~69-90.
  • 4姜秀杰,胡元清,马数艳.射频消融联合肝动脉化疗栓塞治疗原发性肝癌的临床探讨[J].中外健康文摘,2013,17(3):156-156.
  • 5European Association for the Study of The Liver;European Organisation for Research and Treatment of Cancer.EASLEORTC clinical practice guidelines:management of hepatocellular carcinoma[J].J Hepatol,2012,56(4):908-943.
  • 6Wang XY,Chen D,Zhang XS,et al.Value of 1FFDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation:a comparative study with contrast-enhanced ultrasound[J].J Dig Dis,2013,14(8):433-438.
  • 7Choi C, Koom WS, Kim TH, et al. A Prospective Phase 2 Multicenter Study for the Efficacy of Radiation Therapy Fol- lowing Incomplete Transarterial Chemoembolization in Unre- sectable Hepatocellular Carcinoma EJ~. Int J Radiat Oncol Biol Phys, 2014, 90(5): 1051-1060.
  • 8Cruz JE, Saksena R, Jabbour SK, et al. The power of genes: a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan eluted microspheres for me- tastatic colon cancer [J]. Ann Pharmacother, 2014, 48 (12)1646 -1650.
  • 9Tang YL, Qi XS, Guo XZ. Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemo- embolization Alone for the Treatment of Hepatocellular Carci- noma: A Meta analysis of Observational Studies [J]. Asian Pac J Cancer Prey, 2015, 16(17) :7871-7874.
  • 10Hammond JS, Franko J, Holloway SE, et al. Gemcitabine tran- scatheter arterial chemoembolization for unresectable hepatocel- lular carcinoma [J]. Hepatogastroenterology, 2014, 61 (133) : 1339-1343.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部